Trial Profile
A Phase I, Double-blind, Placebo-controlled, Randomized, Multiple-dose, Dose-ascending Study to Evaluate the Safety, Tolerability, Pharmacokinetics and to explore Pharmacodynamic trends after oral administration of TRC150094 in Overweight/Obese Male and Female Subjects with other non traditional CV risk factors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Sep 2016
Price :
$35
*
At a glance
- Drugs Omzotirome (Primary)
- Indications Metabolic syndrome
- Focus Adverse reactions
- Sponsors Torrent Pharmaceuticals
- 06 Dec 2010 New trial record